AMD vs LCTX · P/E 157, rev $11.54B vs rev $9.5M
Advanced Micro Devices Inc (AMD) versus Lineage Cell Therapeutics Inc (LCTX) — a side-by-side from cached financials, not a winner call.
Advanced Micro Devices Inc (AMD) is a semiconductors company listed on US. It is led by Lisa Su.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Latest reported AMD revenue for 2026-06-27 was $11.54B. Net income was $2.30B. Revenue was up 12.5% from 2026-03-28 to 2026-06-27. AMD currently screens at market cap $760.48B and trailing P/E 156.5.
Latest reported LCTX revenue for 2024-12-31 was $9.5M. Net income was -$18.6M. Revenue was up 354.9% from 2023-12-31 to 2024-12-31. LCTX currently screens at market cap $213.6M.
AMD currently screens at market cap $760.48B and trailing P/E 156.5. LCTX currently screens at market cap $213.6M.
Not investment advice. Open the AMD and LCTX stock pages for the full models.
Not investment advice.